Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: Descending monoamine system and opioid receptors are differentially involved

Neuropharmacology

Volumn 62, Issue 2, 2012, Pages 843-854

  Zhao, Xin ^a,b   Xu, Ying ^c   Zhao, Qing ^d   Chen, Chang Rui ^a   Liu, Ai Ming ^b   Huang, Zhi Li ^a  

^a FUDAN UNIVERSITY   (China)

^b NINGBO UNIVERSITY   (China)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d Putuo District Center Hospital   (China)

Author keywords

Antinociceptive effects; Curcumin; Monoamine; Neuropathic pain; Opioid

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR; BETA FUNALTREXAMINE; CURCUMIN; DELTA OPIATE RECEPTOR; FENCLONINE; MONOAMINE; MU OPIATE RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NALTRINDOLE; NORADRENALIN; OXIDOPAMINE; SEROTONIN; SEROTONIN 1A RECEPTOR;

ACUTE DRUG ADMINISTRATION; ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DESCENDING MONOAMINERGIC SYSTEM; DOSE RESPONSE; DRUG MECHANISM; EVENING DOSAGE; HYPERALGESIA; MALE; MECHANICAL STIMULATION; MONOAMINERGIC SYSTEM; MORNING DOSAGE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; SEROTONIN RELEASE; THERMAL STIMULATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CURCUMIN; HYPERALGESIA; MALE; MICE; NARCOTIC ANTAGONISTS; NEURALGIA; NOREPINEPHRINE; PAIN MEASUREMENT; PIPERAZINES; PROPANOLAMINES; PYRIDINES; RECEPTORS, OPIOID; SCIATIC NEUROPATHY; SEROTONIN; SEROTONIN ANTAGONISTS; SPINAL CORD;

EID: 84855966219     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.08.050     Document Type: Article

References (57)

1. S. Arnér, and B.A. Meyerson Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain Pain 33 1988 11 23
2. N. Attal, G. Cruccu, R. Baron, M. Haanpää, P. Hansson, T.S. Jensen, and T. Nurmikko EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision Eur. J. Neurol. 17 2010 1113 1123
3. A. Baghdasaryan, T. Claudel, A. Kosters, J. Gumhold, D. Silbert, A. Thüringer, K. Leski, P. Fickert, S.J. Karpen, and M. Trauner Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation Gut 59 2010 521 530
4. 1A receptors in morphine analgesia and tolerance in rats Eur. J. Pain 8 2004 253 261
5. 1A receptor-mediated, behaviorally specific analgesia Eur. J. Pharmacol. 421 2001 109 114
6. M. Barrot, I. Yalcin, N. Choucair-Jaafar, M. Benbouzid, and M.J. Freund-Mercier From antidepressant drugs to beta-mimetics: preclinical insights on potential new treatments for neuropathic pain Recent Pat. C.N.S Drug Discov. 4 2009 182 189
7. M. Barrot, I. Yalcin, L.H. Tessier, and M.J. Freund-Mercier Antidepressant treatment of neuropathic pain: looking for the mechanism Future Neurol. 5 2010 247 257
8. M. Benbouzid, N. Choucair-Jaafar, I. Yalcin, E. Waltisperger, A. Muller, M.J. Freund-Mercier, and M. Barrot Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice Eur. J. Pain 12 2008 1008 1017
9. M. Benbouzid, C. Gavériaux-Ruff, I. Yalcin, E. Waltisperger, L.H. Tessier, A. Muller, B.L. Kieffer, M.J. Freund-Mercier, and M. Barrot Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia Biol. Psychiatry 63 2008 633 636
10. G.J. Bennett, and Y.K. Xie A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man Pain 33 1988 87 107
11. Y. Bohren, D. Karavelic, L.H. Tessier, I. Yalcin, C. Gavériaux- Ruff, B.L. Kieffer, M.J. Freund-Mercier, and M. Barrot Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia Eur. J. Pain 14 2010 700 704
12. S.F. Bomholt, J.D. Mikkelsen, and G. Blackburn-Munro Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain Neuropharmacology 48 2005 252 263
13. D. Bridges, S.W. Thompson, and A.S. Rice Mechanisms of neuropathic pain Br. J. Anaesth. 87 2001 12 26
14. M. Chiappedi, and M. Bejor Herbals and natural dietary supplements in psychiatric practice Recent Pat. C.N.S Drug Discov. 5 2010 164 171
15. N. Choucair-Jaafar, I. Yalcin, J.L. Rodeau, E. Waltisperger, M.J. Freund-Mercier, and M. Barrot Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment Br. J. Pharmacol. 158 2009 1683 1694
16. 1A receptor activation: a new mechanism of profound, central analgesia Neuropharmacology 43 2002 945 958
17. E. Eisenberg, E.D. McNicol, and D.B. Carr Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials J.A.M.A 293 2005 3043 3052
18. N.B. Finnerup, M. Otto, H.J. McQuay, T.S. Jensen, and S.H. Sindrup Algorithm for neuropathic pain treatment: an evidence based proposal Pain 118 2005 289 305
19. T. Gutierrez, A.G. Nackley, M.H. Neely, K.G. Freeman, G.L. Edwards, and A.G. Hohmann Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception Brain Res. 987 2003 176 185
20. T.J. Haley, and W.G. McCormick Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse Br. J. Pharmacol. Chemother. 12 1957 12 15
21. R.N. Harden Chronic neuropathic pain. Mechanisms, diagnosis, and treatment Neurologist 11 2005 111 122
22. 2A/2C receptors Neuropharmacology 51 2006 866 872
23. J.L. Hylden, and G.L. Wilcox Intrathecal morphine in mice: a new technique Eur. J. Pharmacol. 67 1980 313 316
24. K.C. Jackson 2nd Pharmacotherapy for neuropathic pain Pain Pract. 6 2006 27 33
25. A.K. Kanodia, A.T. Legedza, R.B. Davis, D.M. Eisenberg, and R.S. Phillips Perceived benefit of Complementary and Alternative Medicine (CAM) for back pain: a national survey J. Am. Board Fam. Med. 23 2010 354 362
26. S.K. Kulkarni, M.K. Bhutani, and M. Bishnoi Antidepressant activity of curcumin: involvement of serotonin and dopamine system Psychopharmacology (Berl) 201 2008 435 442
27. D. Labuz, S.A. Mousa, M. Schäfer, C. Stein, and H. Machelska Relative contribution of peripheral versus central opioid receptors to antinociception Brain Res. 1160 2007 30 38
28. J. Lin, S. Zheng, and A. Chen Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress Lab. Invest. 89 2009 1397 1409
29. F. Marchand, D. Ardid, E. Chapuy, A. Alloui, D. Jourdan, and A. Eschalier Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats J. Pharmacol. Exp. Ther. 307 2003 268 274
30. J.A. Micó, D. Ardid, E. Berrocoso, and A. Eschalier Antidepressants and pain Trends Pharmacol. Sci. 27 2006 348 354
31. M.J. Millan Descending control of pain Prog. Neurobiol. 66 2002 355 474
32. N. Mittal, R. Joshi, D. Hota, and A. Chakrabarti Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat Phytother. Res. 23 2009 507 512
33. R. Nicholson, A.K. Dixon, D. Spanswick, and K. Lee Noradrenergic receptor mRNA expression in adult rat superficial dorsal horn and dorsal root ganglion neurons Neurosci. Lett. 380 2005 316 321
34. C. Nozaki, and J. Kamei Possible involvement of opioidergic systems in the anti-nociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice Eur. J. Pharmacol. 552 2006 99 104
35. Pillai G. Radhakrishna, A.S. Srivastava, T.I. Hassanein, D.P. Chauhan, and E. Carrier Induction of apoptosis in human lung cancer cells by curcumin Cancer Lett. 208 2004 163 170
36. K.H. Reeta, J. Mehla, and Y.K. Gupta Curcumin ameliorates cognitive dysfunction and oxidative damage in phenobarbitone and carbamazepine administered rats Eur. J. Pharmacol. 644 2010 106 112
37. G. Scherrer, N. Imamachi, Y.Q. Cao, C. Contet, F. Mennicken, D. O'Donnell, B.L. Kieffer, and A.I. Basbaum Dissociation of the opioid receptor mechanisms that control mechanical and heat pain Cell 137 2009 1148 1159
38. S. Sharma, S.K. Kulkarni, J.N. Agrewala, and K. Chopra Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain Eur. J. Pharmacol. 536 2006 256 261
39. S. Shishodia, G. Sethi, and B.B. Aggarwal Curcumin: getting back to the roots Ann. N. Y. Acad. Sci. 1056 2005 206 217
40. T. Suzuki, Y.H. Li, and T. Mashimo The anti-allodynic and antihyperalgesic effects of neurotropin in mice with spinal nerve ligation Anesth. Analg. 101 2005 793 799
41. T. Suzuki, K. Ueta, S. Tamagaki, and T. Mashimo Anti-allodynic and antihyperalgesic effect of milnacipran in mice with spinal nerve ligation Anesth. Analg. 106 2008 1309 1315
42. H. Tajik, E. Tamaddonfard, and N. Hamzeh-Gooshchi The effect of curcumin (active substance of turmeric) on the acetic acid-induced visceral nociception in rats Pak. J. Biol. Sci. 11 2008 312 314
43. Y. Takeuchi, K. Takasu, H. Ono, and M. Tanabe Pregabalin, -(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model Neuropharmacology 53 2007 842 853
44. M. Tanabe, Y. Tokuda, K. Takasu, K. Ono, M. Honda, and H. Ono The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems Br. J. Pharmacol. 150 2007 403 414
45. C. Vogel, R. Mössner, M. Gerlach, T. Heinemann, D.L. Murphy, P. Riederer, K.P. Lesch, and C. Sommer Absence of thermal hyperalgesia in serotonin transporter-deficient mice J. Neurosci. 23 2003 708 715
46. K.M. Von, and G. Simon The relationship between pain and depression Br. J. Psychiatry Suppl. 30 1996 101 108
47. T. Vo, A.S. Rice, and R.H. Dworkin Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use? Pain 143 2009 169 171
48. 2 receptors Eur. J. Pharmacol. 578 2008 43 50
49. Y. Xu, B. Ku, L. Cui, X. Li, P.A. Barish, T.C. Foster, and W.O. Ogle Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats Brain Res. 1162 2007 9 18
50. Y. Xu, B.S. Ku, H.Y. Yao, Y.H. Lin, X. Ma, Y.H. Zhang, and X.J. Li The effects of curcumin on depressive-like behaviors in mice Eur. J. Pharmacol. 518 2005 40 46
51. Y. Xu, D. Lin, S. Li, G. Li, S.G. Shyamala, P.A. Barish, M.M. Vernon, J. Pan, and W.O. Ogle Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress Neuropharmacology 57 2009 463 471
52. 2-adrenoceptors are critical for antidepressant treatment of neuropathic pain Ann. Neurol. 65 2009 218 225
53. 2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain Neurobiol. Dis. 33 2009 386 394
54. V.S. Yadav, K.P. Mishra, D.P. Singh, S. Mehrotra, and V.K. Singh Immunomodulatory effects of curcumin Immunopharmacol. Immunotoxicol. 27 2005 485 497
55. K.Y. Yeon, S.A. Kim, Y.H. Kim, M.K. Lee, D.K. Ahn, H.J. Kim, J.S. Kim, S.J. Jung, and S.B. Oh Curcumin produces an antihyperalgesic effect via antagonism of TRPV1 J. Dent. Res. 89 2010 170 174
56. 2+ channel enhanced morphine analgesia and reduced morphine tolerance Eur. J. Neurosci. 20 2004 3516 3519
57. G. Zareba Phytotherapy for pain relief Drugs Today (Barc) 45 2009 445 467